Aptevo Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.93 | -$1.93 | -$1.93 |
| Q2 2024 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q3 2024 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q1 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q4 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
Aptevo Therapeutics Inc. Earnings Date And Information
Aptevo Therapeutics Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.48 earnings per share for the quarter, topping analysts' consensus estimates of $-0.57 by $0.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Aptevo Therapeutics Inc. has generated $-72 earnings per share over the last year ($-67.07 diluted earnings per share) and currently has a price-to-earnings ratio of -0.12. Aptevo Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Aptevo Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.57 | -$0.48 | 0.09 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$1.93 | -$1.67 | 0.26 | $0 | $0 |
| 05/08/2024 | Q1 2024 | -$14.10 | -$9.95 | 4.15 | $0 | |
| 03/05/2024 | Q4 2023 | -$18.04 | -$11.85 | 6.19 | $902,000 | |
| 09/29/2023 | Q3 2023 | -$22.16 | $0 | |||
| 08/10/2023 | Q2 2023 | -$49.34 | -$54.12 | -4.78 | $0 | |
| 05/11/2023 | Q1 2023 | -$52.42 | $71.49 | 123.91 | $0 | |
| 03/30/2023 | Q4 2022 | $251.60 | $-3,114,000 | |||
| 11/10/2022 | Q3 2022 | -$72.25 | -$66.29 | 5.96 | $0 | |
| 08/11/2022 | Q2 2022 | -$58.59 | $244.04 | 302.63 | $3.45 M | $0 |
| 05/12/2022 | Q1 2022 | -$50.66 | -$88.77 | -38.11 | $3.11 M | |
| 03/24/2022 | Q4 2021 | -$1.29 | -$56.32 | -55.03 | $3.67 M | |
| 11/12/2021 | Q3 2021 | -$65.20 | -$63.08 | 2.12 | $3.10 M | $3.10 M |
| 08/12/2021 | Q2 2021 | -$85.90 | -$77.04 | 8.86 | $1.35 M | $3.11 M |
| 05/11/2021 | Q1 2021 | -$71.37 | -$72.26 | -0.89 | $2.42 M | |
| 03/31/2021 | Q4 2020 | -$80.32 | $2.37 M | |||
| 11/10/2020 | Q3 2020 | -$90.31 | -$92.43 | -2.12 | $563,667 | $1.46 M |
| 08/14/2020 | Q2 2020 | -$100.00 | -$92.59 | 7.41 | $290,000 | $473,000 |
| 05/13/2020 | Q1 2020 | -$112.33 | -$134.57 | -22.24 | $0 | |
| 03/25/2020 | Q4 2019 | -$3.59 | -$111.09 | -107.5 | $9.03 M |
Aptevo Therapeutics Inc. Earnings: Frequently Asked Questions
-
When is Aptevo Therapeutics Inc.'s earnings date?
Aptevo Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
-
Did Aptevo Therapeutics Inc. beat their earnings estimates last quarter?
In the previous quarter, Aptevo Therapeutics Inc. (:APVO) reported $-0.48 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.57 by $0.09.
-
How can I listen to Aptevo Therapeutics Inc.'s earnings conference call?
The conference call for Aptevo Therapeutics Inc.'s latest earnings report can be listened to online.
-
How can I read Aptevo Therapeutics Inc.'s conference call transcript?
The conference call transcript for Aptevo Therapeutics Inc.'s latest earnings report can be read online.
-
How much profit does Aptevo Therapeutics Inc. generate each year?
Aptevo Therapeutics Inc. (:APVO) has a recorded net income of $0. Aptevo Therapeutics Inc. has generated $-72.01 earnings per share over the last four quarters.
-
What is Aptevo Therapeutics Inc.'s price-to-earnings ratio?
Aptevo Therapeutics Inc. (:APVO) has a price-to-earnings ratio of -0.12 and price/earnings-to-growth ratio is -0.
